𝔖 Bobbio Scriptorium
✦   LIBER   ✦

34 Detectable HBV-specific T cell responses in liver transplant recipients: A comparison to chronic hepatitis B

✍ Scribed by E. Loggi; F.K. Bihl; J.V. Chisholm III; L. Testa; C. Cursaro; M. Biselli; A.D. Pinna; M. Bernardi; C. Brander; P. Andreone

Book ID
117374316
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
260 KB
Volume
44
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Sustained and focused hepatitis B virus
Sustained and focused hepatitis B virus nucleocapsid–specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection
✍ Florian Bihl; Elisabetta Loggi; John V. Chisholm III; Maurizio Biselli; Maria C. πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 218 KB πŸ‘ 1 views

Hepatitis B virus (HBV) recurrence after orthotopic liver transplantation (OLT) is associated with poor graft-and patientsurvival. Treatment with HBV-specific immunoglobulins (HBIG) in combination with nucleos(t)ide analogs is effective in preventing HBV reinfection of the graft and improving OLT ou

Vaccination against hepatitis B in liver
Vaccination against hepatitis B in liver transplant recipients: Pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells
✍ Tanja Bauer; Matthias GΓΌnther; Ulrich Bienzle; Ruth Neuhaus; Wolfgang Jilg πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 214 KB πŸ‘ 1 views

After liver transplantation for hepatitis-B-related diseases, patients currently receive lifelong treatment with hepatitis B immunoglobulin to prevent endogenous reinfection with hepatitis B virus (HBV). Active immunization with hepatitis B vaccine would be a preferable alternative; however, most at